Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
Targeting the glycolytic PFKFB3 enzyme is being studied as a therapeutic strategy against cancer. Here the authors identify PFKFB3 as being involved in homologous recombination (HR) repair of DNA double strand breaks (DSBs) and present a PFKFB3 inhibitor.
Principais autores: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Nature Portfolio
2018-09-01
|
coleção: | Nature Communications |
Acesso em linha: | https://doi.org/10.1038/s41467-018-06287-x |